Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil

Value in Health- United Kingdom

doi 10.1016/j.jval.2017.08.2661

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV


Related search